Mouse VEGF164 Antibody

Catalog # Availability Size / Price Qty
AF-493-NA
AF-493-SP
Detection  of Recombinant Human, Mouse, and Rat VEGF by Western Blot.
3 Images
Product Details
Citations (64)
FAQs
Supplemental Products
Reviews (1)

Mouse VEGF164 Antibody Summary

Species Reactivity
Mouse
Specificity
Detects mouse VEGF in ELISAs and Western blots. In Western blots, detection of recombinant mouse (rm) VEGF164, rmVEGF120, rmVEGF188, and recombinant rat VEGF164 is observered but no cross-reactivity with rmVEGF-B167,rmVEGF-B186 , or recombinant human (rh) VEGF165 is observed. In sandwich immunoassays, less than 0.04% cross-reactivity with rhVEGF121, rhVEGF165, and rhVEGF/PlGF is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse VEGF164
Ala27-Arg190
Accession # AAA40547
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
See below
Immunohistochemistry
5-15 µg/mL
See below

Mouse VEGF Sandwich Immunoassay

Recommended Concentration
Reagent
ELISA Capture (Matched Antibody Pair)
0.2-0.8 µg/mL 

Use in combination with:

Detection Reagent: Mouse VEGF Biotinylated Antibody (Catalog # BAF493)

Standard: Recombinant Mouse VEGF 164 Protein (Catalog # 493-MV)

Neutralization
Measured by its ability to neutralize VEGF164-induced proliferation in HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci USA 87:1323. The Neutralization Dose (ND50) is typically 0.05‑0.15 µg/mL in the presence of 10 ng/mL Recombinant Mouse VEGF164.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Data Examples

Western Blot Detection  of Recombinant Human, Mouse, and Rat VEGF by Western Blot. View Larger

Detection of Recombinant Human, Mouse, and Rat VEGF by Western Blot. Western blot shows 25 ng of Recombinant Human VEGF165 (Catalog # 293-VE), Recombinant Mouse VEGF164 (Catalog # 493-MV), Recombinant Mouse VEGF120 (Catalog # 494-VE), Recombinant Mouse VEGF‑B167 (Catalog # 2595-VE), Recombinant Mouse VEGF‑B 186 (Catalog # 767-VE), Recombinant Mouse VEGF188 (Catalog # 7916-MV), and Recombinant Rat VEGF164 (Catalog # 564-RV). PVDF Membrane was probed with 0.1 µg/mL of Goat Anti-Mouse VEGF164 Antigen Affinity-purified Polyclonal Antibody (Catalog #
AF-493-NA) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for VEGF at approximately 18-27 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 3.

Immunohistochemistry VEGF164 in Mouse Kidney. View Larger

VEGF164 in Mouse Kidney. Vascular Endothelial Growth Factor 164 (VEGF164) was detected in perfusion fixed frozen sections of mouse kidney using Goat Anti-Mouse VEGF164 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-493-NA) at 15 µg/mL overnight at 4 °C. Tissue was stained (red) and counterstained (green). View our protocol for Fluorescent IHC Staining of Frozen Tissue Sections.

Neutralization Cell Proliferation Induced by VEGF164 and Neutralization by Mouse VEGF Antibody. View Larger

Cell Proliferation Induced by VEGF164 and Neutralization by Mouse VEGF Antibody. Recombinant Mouse VEGF164 (Catalog # 493-MV) stimulates proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Mouse VEGF164 (10 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Mouse VEGF164 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-493-NA). The ND50 is typically 0.05-0.15 µg/mL.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Reconstitution Buffer Available
Reconstitution Buffer 1 (PBS)
Catalog #
Availability
Size / Price
Qty
RB01
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VEGF

Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult (1-3). It is a member of the PDGF family that is characterized by a cystine knot structure formed by eight conserved cysteine residues (4). Alternately spliced isoforms of 121, 145, 165, 183, 189, and 206 amino acids (aa) have been identified in humans, with 120, 164 and 188 aa isoforms found in mouse (2, 4). Isoforms other than VEGF120 and VEGF121 contain basic heparin-binding regions and are not freely diffusible (4). Mouse VEGF164 shares 97% aa sequence identity with corresponding regions of rat, 89% with human and porcine, 88% with bovine, and 90% with feline, equine and canine VEGF, respectively. VEGF binds the type I transmembrane receptor tyrosine kinases VEGF R1 (also called Flt-1) and VEGF R2 (Flk-1/KDR) on endothelial cells (4). Although affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity (3, 4). Human VEGF165 binds the semaphorin receptor, Neuropilin-1 and promotes complex formation with VEGF R2 (5). VEGF is required during embryogenesis to regulate the proliferation, migration, and survival of endothelial cells (3, 4). In adults, VEGF functions mainly in wound healing and the female reproductive cycle (3). Pathologically, it is involved in tumor angiogenesis and vascular leakage (6, 7). Circulating VEGF levels correlate with disease activity in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus (8). VEGF is induced by hypoxia and cytokines such as IL-1, IL-6, IL-8, oncostatin M and TNF-alpha (3, 4, 9).

References
  1. Breier, G. et al. (1992) Development 114:521.
  2. Shima, D.T. et al. (1996) J. Biol. Chem. 271:3877.
  3. Byrne, A.M. et al. (2005) J. Cell. Mol. Med. 9:777.
  4. Robinson, C.J. and S.E. Stringer (2001) J. Cell. Sci. 114:853.
  5. Pan, Q. et al. (2007) J. Biol. Chem. 282:24049.
  6. Weis, S.M. and D.A. Cheresh (2005) Nature 437:497.
  7. Thurston, G. (2002) J. Anat. 200:575.
  8. Carvalho, J.F. et al. (2007) J. Clin. Immunol. 27:246.
  9. Angelo, L.S. and R. Kurzrock (2007) Clin. Cancer Res. 13:2825.
Long Name
Vascular Endothelial Growth Factor
Entrez Gene IDs
7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish)
Alternate Names
MVCD1; VAS; vascular endothelial growth factor A; Vascular permeability factor; Vasculotropin; VEGF; VEGFA; VEGF-A; VEGFMGC70609; VPF; VPFvascular endothelial growth factor

Product Datasheets

Citations for Mouse VEGF164 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

64 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy
    Authors: J Ding, X Tan, K Song, W Ma, J Xiao, Y Song, M Zhang
    Front Pharmacol, 2018;9(0):437.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: WB
  2. Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism
    Authors: J Chen, Y Qiao, B Tang, G Chen, X Liu, B Yang, J Wei, X Zhang, X Cheng, P Du, W Jiang, Q Hu, ZC Hua
    Theranostics, 2017;7(8):2250-2260.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neut
  3. VEGF as a Paracrine Regulator of Conventional Outflow Facility
    Authors: E Reina-Torr, JC Wen, KC Liu, G Li, JM Sherwood, JY Chang, P Challa, CM Flügel-Koc, WD Stamer, RR Allingham, DR Overby
    Invest. Ophthalmol. Vis. Sci., 2017;58(3):1899-1908.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  4. Intrafibrillar silicified collagen scaffold modulates monocyte to promote cell homing, angiogenesis and bone regeneration
    Authors: Ji-Hua Chen
    Biomaterials, 2017;113(0):203-216.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neut
  5. Ferrochelatase is a therapeutic target for ocular neovascularization
    Authors: HD Basavaraja, RS Sulaiman, X Qi, T Shetty, S Sheik Pran, KL Sishtla, B Lee, J Quigley, S Alkhairy, CM Briggs, K Gupta, B Tang, M Shadmand, MB Grant, ME Boulton, SY Seo, TW Corson
    EMBO Mol Med, 2017;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Functional Assay
  6. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes
    Authors: T Hara, HJ Nakaoka, T Hayashi, K Mimura, D Hoshino, M Inoue, F Nagamura, Y Murakami, M Seiki, T Sakamoto
    Proc. Natl. Acad. Sci. U.S.A., 2017;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neut
  7. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis
    Authors: XW Chen, TJ Yu, J Zhang, Y Li, HL Chen, GF Yang, W Yu, YZ Liu, XX Liu, CF Duan, HL Tang, M Qiu, CL Wang, H Zheng, J Yue, AM Guo, J Yang
    Oncogene, 2017;0(0):.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: Functional Assay
  8. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy
    Sci Rep, 2016;6(0):25509.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neut
  9. Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro
    Sci Rep, 2016;6(0):31572.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neut
  10. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism
    Authors: C Zhao, W Zhang, Y Zhao, Y Yang, H Luo, G Ji, E Dong, H Deng, S Lin, Y Wei, H Yang
    Sci Rep, 2016;6(0):19404.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neut
  11. The biomechanical properties of an epithelial tissue determine the location of its vasculature
    Nat Commun, 2016;7(0):13560.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  12. A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina
    Authors: Akane Morita
    Dev. Dyn, 2016;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  13. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently
    Authors: L Zheng, C Zhao, Y Du, X Lin, Y Jiang, C Lee, G Tian, J Mi, X Li, Q Chen, Z Ye, L Huang, S Wang, X Ren, L Xing, W Chen, D Huang, Z Gao, S Zhang, W Lu, Z Tang, B Wang, R Ju, X Li
    Oncotarget, 2016;7(47):77902-77915.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neut
  14. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
    Mol Ther Methods Clin Dev, 2016;3(0):16056.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  15. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate
    Clin Cancer Res, 2016;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  16. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
    Authors: Bonapace L, Coissieux M, Wyckoff J, Mertz K, Varga Z, Junt T, Bentires-Alj M
    Nature, 2015;515(7525):130-3.
    Species: Mouse
    Sample Types: In Vivo
  17. Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2.
    Authors: Sitaras N, Rivera J, Noueihed B, Bien-Aime M, Zaniolo K, Omri S, Hamel D, Zhu T, Hardy P, Sapieha P, Joyal J, Chemtob S
    Am J Pathol, 2015;185(2):581-95.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Neut
  18. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1alpha activation.
    Authors: Park S, Lee S, Kim H, Lee W, Hong K, Kim C
    Eur J Immunol, 2015;45(4):1216-27.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC Paraffin-embedded
  19. An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice.
    Authors: Runge A, Hu J, Wieland M, Bergeest J, Mogler C, Neumann A, Geraud C, Arnold B, Rohr K, Komljenovic D, Schirmacher P, Goerdt S, Augustin H
    Cancer Res, 2014;74(15):4157-69.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC Paraffin-embedded
  20. Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability.
    Authors: Hendel, Alon, Hsu, Ivy, Granville, David J
    Lab Invest, 2014;94(7):716-25.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neut
  21. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages.
    Authors: Lee Y, Park H, Woo S, Park E, Kang J
    J Pharmacol Exp Ther, 2014;350(3):563-77.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neut
  22. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain.
    Authors: Zeng, L, He, X, Wang, Y, Tang, Y, Zheng, C, Cai, H, Liu, J, Wang, Y, Fu, Y, Yang, G-Y
    Gene Ther, 2014;21(1):37-43.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-OCT embedded
  23. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.
    Authors: Valcarcel M, Carrascal T, Crende O, Vidal-Vanaclocha F
    J Invest Dermatol, 2014;134(2):470-80.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neut
  24. IKK2 inhibition attenuates laser-induced choroidal neovascularization.
    Authors: Lu H, Lu Q, Gaddipati S, Kasetti R, Wang W, Pasparakis M, Kaplan H, Li Q
    PLoS ONE, 2014;9(1):e87530.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  25. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
    Authors: Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman J, Remuzzi G, Zoja C, Morigi M
    J Am Soc Nephrol, 2014;25(8):1786-98.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  26. Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage.
    Authors: Lee, Junyeop, Park, Dae-Youn, Park, Do Young, Park, Intae, Chang, Woohyok, Nakaoka, Yoshikaz, Komuro, Issei, Yoo, Ook-Joon, Koh, Gou Youn
    Invest Ophthalmol Vis Sci, 2014;55(4):2191-9.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: WB
  27. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis.
    Authors: Lee E, Fertig E, Jin K, Sukumar S, Pandey N, Popel A
    Nat Commun, 2014;5(0):4715.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  28. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments.
    Authors: Sprague L, Muccioli M, Pate M, Singh M, Xiong C, Ostermann A, Niese B, Li Y, Li Y, Courreges M, Benencia F
    Exp Cell Res, 2014;323(1):7-27.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: ELISA detection
  29. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) in the brain.
    Authors: Yu S, Levi L, Casadesus G, Kunos G, Noy N
    J Biol Chem, 2014;289(18):12748-58.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: WB
  30. G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis.
    Authors: Raghuwanshi S, Smith N, Rivers E, Thomas A, Sutton N, Hu Y, Mukhopadhyay S, Chen X, Leung T, Richardson R
    J Immunol, 2013;190(10):5329-36.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: ELISA Capture
  31. The role of IL-1beta in the early tumor cell-induced angiogenic response.
    Authors: Carmi Y, Dotan S, Rider P, Kaplanov I, White M, Baron R, Abutbul S, Huszar M, Dinarello C, Apte R, Voronov E
    J Immunol, 2013;190(7):3500-9.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  32. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
    Authors: Pushpakumar, Sathnur, Kundu, Sourav, Metreveli, Naira, Sen, Utpal
    PLoS ONE, 2013;8(12):e83813.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: WB
  33. Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor beta2 (TGF-beta2) pathways.
    Authors: Di Bernardini E, Campagnolo P, Margariti A, Zampetaki A, Karamariti E, Hu Y, Xu Q
    J Biol Chem, 2013;289(6):3383-93.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neut
  34. Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D.
    Authors: Tan K, Chong S, Wong F, Evrard M, Tan S, Keeble J, Kemeny D, Ng L, Abastado J, Angeli V
    Blood, 2013;122(22):3666-77.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  35. Response patterns of cytokines/chemokines in two murine strains after irradiation.
    Authors: Zhang M, Yin L, Zhang K, Sun W, Yang S, Zhang B, Salzman P, Wang W, Liu C, Vidyasagar S, Zhang L, Ju S, Okunieff P, Zhang L
    Cytokine, 2012;58(2):169-77.
    Species: Mouse
    Sample Types: Plasma
    Applications: Luminex Assay Development
  36. Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice.
    Blood, 2012;119(26):6382-93.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  37. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway.
    Authors: Furrer K, Rickenbacher A, Tian Y, Jochum W, Bittermann AG, Kach A, Humar B, Graf R, Moritz W, Clavien PA
    Proc. Natl. Acad. Sci. U.S.A., 2011;108(7):2945-50.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  38. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.
    Authors: Liu J, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, Bora PS
    J. Biol. Chem., 2011;286(23):20991-1001.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  39. IL-17 and VEGF are necessary for efficient corneal nerve regeneration.
    Authors: Li Z, Burns AR, Han L, Rumbaut RE, Smith CW
    Am. J. Pathol., 2011;178(3):1106-16.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  40. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.
    Authors: Wuest TR, Carr DJ
    J. Exp. Med., 2010;207(1):101-15, S1-2.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  41. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.
    Authors: Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, Ito A, Misener S, Tanaka T, Klyachko E, Kobayashi K, Tongers J, Roncalli J, Tsurumi Y, Hagiwara N, Losordo DW
    Proc. Natl. Acad. Sci. U.S.A., 2010;107(24):11008-13.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  42. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas.
    Authors: Lederle W, Linde N, Heusel J, Bzyl J, Woenne EC, Zwick S, Skobe M, Kiessling F, Fusenig NE, Mueller MM
    Am. J. Pathol., 2010;176(2):981-94.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: ICC
  43. Role of cell and matrix-bound VEGF isoforms in lens development.
    Authors: Saint-Geniez M, Kurihara T, D'Amore PA
    Invest. Ophthalmol. Vis. Sci., 2009;50(1):311-21.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neut
  44. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.
    Authors: Hakroush S, Moeller MJ, Theilig F, Kaissling B, Sijmonsma TP, Jugold M, Akeson AL, Traykova-Brauch M, Hosser H, Hahnel B, Grone HJ, Koesters R, Kriz W
    Am. J. Pathol., 2009;175(5):1883-95.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC Paraffin-embedded
  45. Safety profile of topical VEGF neutralization at the cornea.
    Authors: Bock F, Onderka J, Rummelt C, Dietrich T, Bachmann B, Kruse FE, Schlotzer-Schrehardt U, Cursiefen C
    Invest. Ophthalmol. Vis. Sci., 2009;50(5):2095-102.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Blocking
  46. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
    Authors: Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ, Spiegel AM, Libutti SK
    Cancer Res., 2009;69(5):1858-66.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC Frozen
  47. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.
    Authors: Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY
    Blood, 2009;113(22):5650-9.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  48. Fibroblast-type reticular stromal cells regulate the lymph node vasculature.
    Authors: Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, Madri JA, Lu TT
    J. Immunol., 2008;181(6):3887-96.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  49. Regulation of scar formation by vascular endothelial growth factor.
    Authors: Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, DiPietro LA
    Lab. Invest., 2008;88(6):579-90.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  50. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.
    Authors: Ponticelli S, Marasco D, Tarallo V, Albuquerque RJ, Mitola S, Takeda A, Stassen JM, Presta M, Ambati J, Ruvo M, De Falco S
    J. Biol. Chem., 2008;283(49):34250-9.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: ELISA Development
  51. Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene.
    Authors: Blouw B, Haase VH, Song H, Bergers G, Johnson RS
    Oncogene, 2007;26(31):4531-40.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  52. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions.
    Authors: Cahill RA, Wang JH, Soohkai S, Redmond HP
    Surgery, 2006;140(1):108-12.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  53. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
    Authors: Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, Evan GI
    Genes Dev., 2006;20(18):2527-38.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development
  54. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain.
    Authors: Le Bras B, Barallobre MJ, Homman-Ludiye J, Ny A, Wyns S, Tammela T, Haiko P, Karkkainen MJ, Yuan L, Muriel MP, Chatzopoulou E, Breant C, Zalc B, Carmeliet P, Alitalo K, Eichmann A, Thomas JL
    Nat. Neurosci., 2006;9(3):340-8.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC Frozen
  55. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.
    Authors: Kajiya K, Hirakawa S, Detmar M
    Am. J. Pathol., 2006;169(4):1496-503.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  56. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
    Authors: Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J
    J. Clin. Invest., 2006;116(2):422-9.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  57. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
    Authors: Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM
    Am. J. Pathol., 2006;169(5):1767-83.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  58. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
    Authors: Kim B, Lee S, Suvas S, Rouse BT
    J. Immunol., 2005;175(1):509-16.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: ELISA Development
  59. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    Authors: Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP
    J. Immunol., 2005;174(1):215-22.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Neut
  60. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone.
    Authors: Katsube K, Bishop AT, Simari RD, Yla-Herttuala S, Friedrich PF
    J. Orthop. Res., 2005;23(2):469-74.
    Species: Rabbit
    Sample Types: Whole Tissue
    Applications: IHC
  61. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    Authors: Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT
    J. Immunol., 2004;172(2):1237-45.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  62. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
    Authors: Kodama I, Sanada M, Yoshiko Y, Tsuda M, Ohama K
    J. Bone Miner. Res., 2004;19(2):200-6.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  63. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
    Authors: Kozawa O, Yoshimi N, Akamatsu S, Hara A, Mori H, Uematsu T
    Blood, 2002;100(7):2487-93.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo
  64. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Authors: Gabrilovich DI, 2018, Ishida T, Nadaf S, Ohm JE, Carbone DP
    1537, 1999;5(10):2963-70.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In vivo

FAQs

  1. What band size(s) are detected when using AF-493-NA for Western blot?

    • This antibody detects Recombinant Mouse VEGF164 at 42 kDa under non-reducing conditions and 21 kDa under reducing conditions.  Band sizes with natural samples may vary slightly depending on any post-translational modifications.  

View all Antibody FAQs

Cell and Tissue Staining Kits

Immunohistochemistry Reagents

Isotype Controls

Reconstitution Buffers

Secondary Antibodies

Reviews for Mouse VEGF164 Antibody

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Mouse VEGF164 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Mouse VEGF164 Antibody
By Anonymous on 04/01/2018
Application: WB Sample Tested: Tumor cell lyastes Species: Mouse